Versor Investments’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-66,200
Closed -$404K – 451
2025
Q4
$404K Buy
+66,200
New +$395K 0.06% 389
2025
Q2
– Sell
-82,650
Closed -$679K – 885
2025
Q1
$679K Sell
82,650
-93,250
-53% -$782K 0.11% 314
2024
Q4
$1.45M Buy
175,900
+60,900
+53% +$489K 0.25% 74
2024
Q3
$880K Buy
115,000
+46,200
+67% +$426K 0.14% 241
2024
Q2
$713K Buy
68,800
+58,200
+549% +$638K 0.13% 239
2024
Q1
$127K Buy
+10,600
New +$118K 0.03% 647
2021
Q4
– Sell
-22,900
Closed -$206K – 635
2021
Q3
$206K Buy
+22,900
New +$185K 0.01% 475
2020
Q1
– Sell
-57,600
Closed -$605K – 329
2019
Q4
$605K Buy
+57,600
New +$521K 0.03% 203

Other funds holding PTEN

Versor Investments's PTEN Position: Q1 2026 in Review

Versor Investments sold out of Patterson-UTI (PTEN) in Q1 2026, closing a stake of 66,200 shares — an estimated $404K sold.

Versor Investments first reported a position in PTEN in Q4 2019 and held it in 8 quarters. The position peaked at $1.45M in Q4 2024. 415 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.

  • Versor Investments reported no remaining Patterson-UTI position as of Q1 2026 after selling out during the quarter.
  • Versor Investments sold 66,200 Patterson-UTI shares in Q1 2026, an estimated $404K.
  • Versor Investments first reported a position in Patterson-UTI in Q4 2019 and held it in 8 quarters.
  • Versor Investments's Patterson-UTI position peaked at $1.45M in Q4 2024.
  • 415 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.

Based on Versor Investments's 13F filing for Q1 2026, filed 12 May 2026.